Carson Wealth (CWM LLC)’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.3K Buy
1,281
+797
+165% +$22.6K ﹤0.01% 3915
2025
Q4
$13K Sell
484
-4,307
-90% -$151K ﹤0.01% 4403
2025
Q3
$192K Sell
4,791
-495
-9% -$18.6K ﹤0.01% 2479
2025
Q2
$176K Buy
5,286
+3,627
+219% +$110K ﹤0.01% 2281
2025
Q1
$49K Buy
1,659
+996
+150% +$33K ﹤0.01% 3007
2024
Q4
$22K Sell
663
-1,504
-69% -$70.7K ﹤0.01% 3362
2024
Q3
$96K Buy
2,167
+1,836
+555% +$83.4K ﹤0.01% 2213
2024
Q2
$14K Buy
331
+162
+96% +$5.85K ﹤0.01% 3323
2024
Q1
$5K Buy
169
+11
+7% +$295 ﹤0.01% 3627
2023
Q4
$4K Buy
158
+131
+485% +$2.94K ﹤0.01% 3570
2023
Q3
$1K Buy
27
+19
+238% +$503 ﹤0.01% 3905
2023
Q2
$0 Sell
8
-6
-43% -$149 ﹤0.01% 4143
2023
Q1
$0 Buy
14
+6
+75% +$159 ﹤0.01% 4013
2022
Q4
$0 Sell
8
-7
-47% -$197 ﹤0.01% 3944
2022
Q3
$0 Hold
15
﹤0.01% 3874
2022
Q2
$0 Buy
15
+8
+114% +$181 ﹤0.01% 3747
2022
Q1
$0 Hold
7
﹤0.01% 3493
2021
Q4
$0 Buy
+7
New +$282 ﹤0.01% 3470
2021
Q2
$0 Hold
7
﹤0.01% 2921
2021
Q1
$0 Hold
7
﹤0.01% 2921
2020
Q4
$0 Hold
7
﹤0.01% 2921
2020
Q3
$0 Hold
7
﹤0.01% 2921
2020
Q2
$0 Hold
7
﹤0.01% 2921
2020
Q1
$0 Hold
7
﹤0.01% 2921
2019
Q4
$0 Hold
7
﹤0.01% 2920
2019
Q3
$0 Hold
7
﹤0.01% 2920
2019
Q2
$0 Hold
7
﹤0.01% 2920
2019
Q1
$0 Buy
+7
New +$408 ﹤0.01% 2926

Other funds holding AGIO

Carson Wealth (CWM LLC)'s AGIO Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Agios Pharmaceuticals (AGIO) stake by 165% in Q1 2026, buying an estimated $22.6K and bringing the position to 1,281 shares worth $43.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3915.

Carson Wealth (CWM LLC) first reported a position in AGIO in Q1 2019 and has held it in 28 quarters since. The position peaked at $192K in Q3 2025. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,281 shares of Agios Pharmaceuticals worth $43.3K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 797 Agios Pharmaceuticals shares in Q1 2026, an estimated $22.6K.
  • Agios Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3915 holding.
  • Carson Wealth (CWM LLC) first reported a position in Agios Pharmaceuticals in Q1 2019 and has held it in 28 quarters since.
  • Carson Wealth (CWM LLC)'s Agios Pharmaceuticals position peaked at $192K in Q3 2025.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.